Premedication With Oral Midazolam in Patients Undergoing Rigid Cystoscopy: A Randomized, Double-blind, Placebo-controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00563069

Enrollment

120

Registered

2007-11-26

Start date

2005-09-30

Completion date

2006-12-31

Last updated

2010-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystoscopy

Keywords

diagnostic and therapeutic rigid cystoscopy

Brief summary

To investigate the efficacy of oral midazolam for patients undergoing rigid cystoscopy in: 1. relieving patient's anxiety and improving satisfaction 2. reducing procedure-related pain 3. facilitating the diagnostic and therapeutic interventions during rigid cystoscopy

Interventions

DRUGMidazolam

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* Elective rigid cystoscopy * Either diagnostic or therapeutic * Age between 18 to 80

Exclusion criteria

* Patients with allergy to midazolam or other benzodiazepine groups * Pregnancy * Emergency rigid cystoscopy * ASA class 3 or above * Patients on psychiatric medications * Alcoholics

Design outcomes

Primary

Measure	Time frame
Pain score during the procedure as assessed by visual analog scale	—

Secondary

Measure	Time frame
Patient's satisfaction	—
Patient's willingness to repeat the procedure	—
Patient's cooperativeness during the procedure as assessed by surgeons	—

Countries

China

Contacts

Primary ContactShirley YW Liu, Dr

liu_yws@yahoo.com.hk(852) 2632 2625

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026